X0201 4 2004-03-15 0 0000761237 IMCOR PHARMACEUTICAL CO ICPH 0001067262 LEVINE STUART P 500 LAKE COOK SUITE 130 DEERFIELD IL 60615 0 0 1 0 Common Stock 2004-03-15 4 G 0 4000 D 475105 D Common Stock 250000 I Owned by family partnership controlled by Reporting Person. Common Stock 25000 I Owned by foundation controlled by the Reporting Person. Call Options (Obligations to Sell) Common Stock 3344045 0 D In addition to shares owned directly by Stuart P. Levine (the "Reporting Person"), shares beneficially owned by the Reporting Person include: (i) 250,000 shares owned by SL Investment Enterprises, LP, and (ii) 25,000 shares owned by the Stuart and Sherri Levine Family Foundation, Inc. During January 31, 2003 though March 15, 2005, the Reporting Person gifted an aggregate of 72,300 shares to various individuals. Under SEC rules, the Reporting Person may be deemed to own an aggregate of 11,881,451 shares covered by a voting, drag-along and right of first refusal agreement dated as of November 12, 2002 where the parties agreed to maintain IMCOR's Board at seven members and to vote to elect certain persons to the Board. The Reporting Person disclaims beneficial ownership of such shares for all other purposes. Note that all share totals set forth herein are after a one for four reverse split of IMCOR Pharmaceutical Co.'s common stock. On October 16, 2002, Tannebaum, LLC granted call options at an exercise price of $.30 per share for all of the shares that it holds in IMCOR Pharmaceutical Co. from time to time at any time between October 16, 2002 and the closing of the call option; the current number of shares subject to call options is 3,344,045. /s/ Stuart Levine 2004-03-15